tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

GPCR Stock Latest News

Structure Therapeutics initiated with an Overweight at Cantor Fitzgerald
The FlyStructure Therapeutics initiated with an Overweight at Cantor Fitzgerald
25d ago
GPCR
Structure Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Structure Therapeutics initiated with an Overweight at Cantor Fitzgerald
25d ago
GPCR
Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference
PremiumPress Releases
Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference
2M ago
GPCR
Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights
PremiumPress Releases
Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights
2M ago
GPCR
Structure Therapeutics expects cash to fund operations through at least 2026
PremiumThe Fly
Structure Therapeutics expects cash to fund operations through at least 2026
2M ago
GPCR
Structure Therapeutics provides GSBR-1290 program update
PremiumThe FlyStructure Therapeutics provides GSBR-1290 program update
5M ago
GPCR
Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical Study
PremiumPress Releases
Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical Study
5M ago
GPCR
Weight-loss drug developers rise after Roche agrees to buy Carmot
PremiumThe Fly
Weight-loss drug developers rise after Roche agrees to buy Carmot
5M ago
ALT
LLY
Structure Therapeutics files to sell 24.02M ordinary share for holders
PremiumThe Fly
Structure Therapeutics files to sell 24.02M ordinary share for holders
6M ago
GPCR
Structure Therapeutics price target raised to $91 from $90 at JMP Securities
PremiumThe Fly
Structure Therapeutics price target raised to $91 from $90 at JMP Securities
6M ago
GPCR
Structure Therapeutics reports Q3 EPS (21c), consensus (29c)
PremiumThe Fly
Structure Therapeutics reports Q3 EPS (21c), consensus (29c)
6M ago
GPCR
Structure Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
PremiumPress Releases
Structure Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
6M ago
GPCR
Structure Therapeutics price target raised to $93 from $58 at Piper Sandler
PremiumThe FlyStructure Therapeutics price target raised to $93 from $58 at Piper Sandler
6M ago
GPCR
Five new option listings and one option delisting on October 25th
PremiumThe Fly
Five new option listings and one option delisting on October 25th
6M ago
GPCR
MAXI
Structure Therapeutics initiated with an Outperform at JMP Securities
PremiumThe Fly
Structure Therapeutics initiated with an Outperform at JMP Securities
7M ago
GPCR
Structure Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Structure Therapeutics management to meet with Piper Sandler
7M ago
GPCR
Structure Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Structure Therapeutics management to meet with Piper Sandler
7M ago
GPCR
Structure Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Structure Therapeutics management to meet with Piper Sandler
7M ago
GPCR
Structure Therapeutics price target raised to $83 from $40 at BMO Capital
PremiumThe Fly
Structure Therapeutics price target raised to $83 from $40 at BMO Capital
7M ago
LLY
GPCR
Structure Therapeutics price target raised to $92 from $50 at Guggenheim
PremiumThe FlyStructure Therapeutics price target raised to $92 from $50 at Guggenheim
7M ago
GPCR
Viking Therapeutics recent 50% selloff ‘excessive,’ says William Blair
PremiumThe Fly
Viking Therapeutics recent 50% selloff ‘excessive,’ says William Blair
7M ago
GPCR
VKTX
Structure Therapeutics price target raised to $97 from $46 at Leerink
PremiumThe Fly
Structure Therapeutics price target raised to $97 from $46 at Leerink
7M ago
LLY
GPCR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >